Bauhinia forficata Link, Antioxidant, Genoprotective, and Hypoglycemic Activity in a Murine Model.
Erika Anayetzi Chávez-BustosÁngel Morales-GonzálezLiliana Anguiano-RobledoEduardo Osiris Madrigal-SantillánCarmen Valadez-VegaOlivia Lugo-MagañaJorge Alberto Mendoza-PérezTomás Alejandro Fregoso-AguilarPublished in: Plants (Basel, Switzerland) (2022)
Bauhinia forficata L. is a tree used in alternative medicine as an anti-diabetic agent, with little scientific information about its pharmacological properties. The hypoglycemic, antioxidant, and genoprotective activities of a methanolic extract of B . forficata leaves and stems combined were investigated in mice treated with streptozotocin (STZ). Secondary metabolites were determined by qualitative phytochemistry. In vitro antioxidant activity was determined by the DPPH method at four concentrations of the extract. The genoprotective activity was evaluated in 3 groups of mice: control, anthracene (10 mg/kg), and anthracene + B. forficata (500 mg/kg) and the presence of micronuclei in peripheral blood was measured for 2 weeks. To determine the hypoglycemic activity, the crude extract was prepared in a suspension and administered (500 mg/kg, i.g.) in previously diabetic mice with STZ (120 mg/kg, i.p.), measuring blood glucose levels every week as well as the animals' body weight for six weeks. The extract showed good antioxidant activity and caused a decrease in the number of micronuclei. The diabetic mice + B . forficata presented hypoglycemic effects in the third week of treatment, perhaps due to its secondary metabolites. Therefore, B. forficata is a candidate for continued use at the ethnomedical level as an adjuvant to allopathic therapy.
Keyphrases
- oxidative stress
- diabetic rats
- anti inflammatory
- blood glucose
- body weight
- peripheral blood
- ms ms
- high fat diet induced
- blood pressure
- randomized controlled trial
- clinical trial
- gestational age
- adipose tissue
- bone marrow
- mass spectrometry
- social media
- glycemic control
- mesenchymal stem cells
- newly diagnosed
- high resolution
- study protocol
- combination therapy
- weight loss
- wild type